Tofajak 5 mg Tablet

Tofajak 5mg Tablet

Tofajak 5mg Tablet contains Tofacitinib 5mg, an oral Janus kinase (JAK) inhibitor manufactured by Cipla used to manage moderate to severe rheumatoid arthritis and other autoimmune inflammatory conditions. It works by selectively blocking JAK enzymes involved in the inflammatory signaling pathway, helping reduce joint pain, swelling, and stiffness while slowing disease progression, offering a convenient oral alternative to injectable biologics.

Key Features

• Contains Tofacitinib 5mg, a targeted oral JAK inhibitor
• Manages moderate to severe rheumatoid arthritis effectively
• Reduces joint inflammation, pain and stiffness
• Convenient oral tablet, an alternative to injectable biologics
• Trusted formulation from Cipla for autoimmune conditions
• Strip of 10 tablets

Key Ingredients

• Tofacitinib 5mg

Uses

Prescribed for the management of rheumatoid arthritis and related inflammatory conditions as directed by a physician or specialist. It may also be prescribed for psoriatic arthritis and ulcerative colitis in certain patients, as determined by a specialist based on individual clinical assessment.

Directions for Use

Take exactly as prescribed by your physician, typically twice daily, with or without food, maintaining a consistent dosing schedule for optimal effectiveness.

Precautions

• Use only as prescribed by a registered physician/specialist
• Regular monitoring of blood counts, liver function, and cholesterol levels is typically required, along with screening for infections before and during treatment.
• Inform your doctor of any existing conditions, infections, or allergies before starting treatment
• Keep away from children

Legal Disclaimer: The product is guaranteed to be 100% genuine. Product images are for illustrative purposes only. This is a prescription medication; use only under medical supervision.